0001104659-16-117764.txt : 20160504 0001104659-16-117764.hdr.sgml : 20160504 20160504173637 ACCESSION NUMBER: 0001104659-16-117764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160502 FILED AS OF DATE: 20160504 DATE AS OF CHANGE: 20160504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUYER DAVID R CENTRAL INDEX KEY: 0001277476 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 161620751 MAIL ADDRESS: STREET 1: ONE PENN PLAZA, 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 4 1 a4.xml 4 X0306 4 2016-05-02 0 0001410939 Ophthotech Corp. OPHT 0001277476 GUYER DAVID R C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 1 1 0 0 Chief Executive Officer Common Stock 2016-05-02 4 M 0 22060 10.03 A 54451 D Common Stock 2016-05-02 4 S 0 17421 46.01 D 37030 D Common Stock 2016-05-02 4 S 0 4639 46.82 D 32391 D Stock Options (Right to Buy) 10.03 2016-05-02 4 M 0 22060 0.00 D 2023-04-25 Common Stock 22060 102724 D The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015. These shares were disposed of in multiple transactions on May 2, 2016 at actual sales prices ranging from $45.56 to $46.55 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on May 2, 2016 at actual sales prices ranging from $46.57 to $47.18 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017. /s/ Justin Vogel, as Attorney-in-Fact for David Guyer 2016-05-04